The recent FDA approval of selinexor (Xpovio) for the treatment of relapsed or refractory multiple myeloma gives hope to patients who have already tried other therapies. This novel drug, however, is not without side effects. Watch now as renowned expert Dr. James Berenson, Medical & Scientific Director at the Institute for Myeloma & Bone Cancer Research, explains the potential side effects of selinexor and how they can be managed. He also discusses the importance of patient-doctor communication.